A study by Li and coworkers demonstrates that antihypertensive-drug use and untreated hypertension in pregnancy increase the risk of congenital malformations. Supported by the results of meta-analysis, this study heralds a major shift in our understanding of the fetal risks of hypertension and the medications used to treat this condition.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology
Journal of Nephrology Open Access 14 June 2018
-
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy
Journal of Nephrology Open Access 17 March 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Li, D. K., Yang, C., Andrade, S., Tavares, V. & Ferber, J. R. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 343, d5931 (2011).
Koren, G., Pastuszak, A. & Ito, S. Drugs in pregnancy. N. Engl. J. Med. 338, 1128–1137 (1998).
Ratnapalan, S. & Koren, G. Taking ACE inhibitors during pregnancy. Is it safe? Can. Fam. Physician 48, 1047–1049 (2002).
Cooper, W. O. et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N. Engl. J. Med. 354, 2443–2451 (2006).
Muntner, P. et al. Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study. J. Clin. Hypertens. (Greenwich) 13, 479–486 (2011).
Källén, B., Nilsson, E. & Olausson, P. O. Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records. Eur. J. Clin. Pharmacol. 67, 839–845 (2011).
Walfisch, A., Al-maawali, A., Moretti, M. E., Nickel, C. & Koren, G. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J. Obstet. Gynaecol. 31, 465–472 (2011).
Chen, C. H. & Lin, H. C. Prenatal care and adverse pregnancy outcomes among women with depression: a nationwide population-based study. Can. J. Psychiatry 56, 273–280 (2011).
Eltonsy, S., Forget, A. & Blais, L. Beta2-agonists use during pregnancy and the risk of congenital malformation. Birth Defects Res. A Clin. Mol. Teratol. 91, 937–947 (2011).
Chang, S. D. et al. Analyses of placental gene expression in pregnancy-related hypertensive disorders. Taiwan J. Obstet. Gynecol. 50, 283–291 (2011).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Koren, G. ACE inhibitor use in pregnancy—setting the record straight. Nat Rev Cardiol 9, 7–8 (2012). https://doi.org/10.1038/nrcardio.2011.179
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2011.179
This article is cited by
-
A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology
Journal of Nephrology (2018)
-
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy
Journal of Nephrology (2016)